FDA Approves Omalizumab for Multiple Food Allergy
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.
The vaccines, Celldemic and Incellipan, protect against the H5N1 subtype of the influenza A virus.
Long-term data show clinical remission and endoscopic response rates are maintained and even improve over time in patients with moderate to severe Crohn's disease, according to a new study.
Is your hair getting a little sparse? Which vitamin deficiency causes hair loss and what you should eat for healthier & thicker locks 2024.
NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.